Brevundimonas vesicularis keratitis after laser in situ keratomileusis.
A 45-year-old woman developed a corneal infiltrate 14 months after laser in situ keratomileusis (LASIK) enhancement in the left eye. The LASIK flap was lifted, scraped, and irrigated with fortified vancomycin and ceftazidime. Scraped samples were cultured and grew Brevundimonas vesicularis. The patient remained on topical ceftazidime until improvement was noted and was then switched to topical levofloxacin. The keratitis resolved on antibiotic agents with strong gram-negative coverage and a steroid. To our knowledge, this is the first report of a B vesicularis ocular infection.
Bascom Palmer Eye Institute, Miami, Florida, USA. jessepelletier@yahoo.com
Jesse S
JS
Pelletier
Takeshi
T
Ide
Sonia H
SH
Yoo
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D042063:Caulobacteraceae / Q000302:isolation & purification*; D002442:Ceftazidime / Q000627:therapeutic use; D003320:Corneal Ulcer / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D003646:Debridement; D004359:Drug Therapy, Combination; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D020731:Keratomileusis, Laser In Situ; D008875:Middle Aged; D011183:Postoperative Complications; D013524:Surgical Flaps / Q000382:microbiology; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014640:Vancomycin; D002442:Ceftazidime